Cargando…
PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy
There is little data concerning the implications of PIK3CA mutations outside of the known hotspots described in ER+/HER2− metastatic breast cancer (mBC). Similarly, PIK3R1 mutations could also lead to activation of PI3K pathway, but are poorly described. We determined the incidence and type of all s...
Autores principales: | Tharin, Zoé, Richard, Corentin, Derangère, Valentin, Ilie, Alis, Arnould, Laurent, Ghiringhelli, François, Boidot, Romain, Ladoire, Sylvain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024711/ https://www.ncbi.nlm.nih.gov/pubmed/36934165 http://dx.doi.org/10.1038/s41598-023-31593-w |
Ejemplares similares
-
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
por: Ballot, Elise, et al.
Publicado: (2022) -
Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
por: Huang, Qingfeng, et al.
Publicado: (2022) -
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
por: Ledys, Fanny, et al.
Publicado: (2018) -
Liver X Receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization
por: Courtaut, Flavie, et al.
Publicado: (2015) -
Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)